A Multicentre, Open-label, Pharmacokinetic Study of Modigraf (Tacrolimus Granules) in de Novo Paediatric Allograft Recipients

Trial Profile

A Multicentre, Open-label, Pharmacokinetic Study of Modigraf (Tacrolimus Granules) in de Novo Paediatric Allograft Recipients

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Allotransplant rejection; Heart transplant rejection; Liver transplant rejection; Renal transplant rejection
  • Focus Pharmacokinetics
  • Acronyms OPTION
  • Sponsors Astellas Pharma; Astellas Pharma Europe Ltd
  • Most Recent Events

    • 22 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 03 Dec 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Sep 2014 to 1 Sep 2015.
    • 03 Dec 2014 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Sep 2014 to 1 Sep 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top